With vaccine sales on the decline, these are tough times for Merck to launch its new pneumococcal shot Capvaxive. | With ...

If you miss the October vaccination window, there is still plenty of time to get protected before Thanksgiving. With ...

Electronic medical records of 42 children with SCD diagnosed between 2009 and 2023 were retrospectively reviewed. Clinical demographic data and pneumococcal serologies were analysed. Of the 42 ...

The good news is — while mental health challenges persist, more residents surveyed have showed greater willingness to seek ...

While the company’s sales outlook was otherwise rosy, Merck took sales hits on Gardisil, Proquad, Varivax and Vaxneuvance.

Officials at the Department of Public Health and Human Services are warning Montanans to take preventive measures as respiratory illness season is coming up qui ...

Our goal is to ensure that everyone in our community has the resources available to live a healthy, safe life. Immunization ...

Merck tops Q3 earnings and revenue estimates on strong oncology, new drugs and animal health sales, while narrowing its 2025 ...

Merck's Q3 2025 results saw huge growth in Winrevair and Capvaxive sales. Check out why I maintain my Strong Buy rating on ...

Compared to its lackluster second quarter performance, Merck rallied somewhat in the third quarter of 2025. Revenue and ...